6533b7d7fe1ef96bd1268634
RESEARCH PRODUCT
Analysis of sequence variations in the LDL receptor gene in Spain: general gene screening or search for specific alterations?
Sebastian BlesaVeronica Gonzalez-albertJosé T. RealSergio Martínez-hervásMaria L. MansegoJuan F. AscasoRafael CarmenaFelipe J. ChavesAna B. García-garcíasubject
GeneticsMutationSequence analysisBiochemistry (medical)Clinical BiochemistryIntronFamilial hypercholesterolemiaSequence Analysis DNABiologymedicine.disease_causemedicine.diseaseHyperlipoproteinemia Type IIExonReceptors LDLSpainLDL receptorMutationmedicineHumansGenetic TestingGeneSequence (medicine)Apolipoproteins BOligonucleotide Array Sequence Analysisdescription
Abstract Background: Familial hypercholesterolemia (FH) is a frequent form of autosomal-dominant hypercholesterolemia that predisposes to premature coronary atherosclerosis. FH is caused by sequence variations in the gene coding for the LDL receptor (LDLR). This gene has a wide spectrum of sequence variations, and genetic diagnosis can be performed by 2 strategies. Methods: Point variations and large rearrangements were screened along all the LDLR gene (promoter, exons, and flanking intron sequences). Results: We screened a sample of 129 FH probands from the Valencian Community, Spain, and identified 54 different LDLR sequence variations. The most frequent (10% of cases) was 111insA, and 60% of the variants had a frequency as low as 1%. A previously described method for detection of known sequence variations in the Spanish population by DNA array analysis allowed the identification of only ∼50% of patients with a variant LDLR gene and ∼40% of the screened samples. Conclusion: Our results indicate that the adequate procedure to identify LDLR sequence variations in outbreed populations should include screening of the entire gene.
year | journal | country | edition | language |
---|---|---|---|---|
2006-06-01 | Clinical chemistry |